(YOUNG INVESTIGATOR AWARD) USE OF PROTONPUMP INHIBITORS AND RISK OF HIP FRACTURE

(YOUNG INVESTIGATOR AWARD) USE OF PROTONPUMP INHIBITORS AND RISK OF HIP FRACTURE

Manylion Llyfryddiaeth
Prif Awduron:	Lalmohamed, A, Pouwels, S, Cooper, C, van Staa, T, Leufkens, B, de Boer, A, de Vries, F
Fformat:	Conference item
Cyhoeddwyd:	2009

Eitemau Tebyg

Use of protonpump inhibitors and risk of hip fracture
gan: Lalmohamed, A, et al.
Cyhoeddwyd: (2009)

Use of Protonpump Inhibitors and Risk of Hip Fracture
gan: Lalmohamed, A, et al.
Cyhoeddwyd: (2009)

(YOUNG INVESTIGATOR AWARD) RISK OF HIP FRACTURE AFTER STROKE: A POPULATION-BASED CASE-CONTROL STUDY
gan: Pouwels, S, et al.
Cyhoeddwyd: (2009)

Risk of hip/femur fracture after stroke: a population-based case-control study.
gan: Pouwels, S, et al.
Cyhoeddwyd: (2009)

Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study.
gan: Pouwels, S, et al.
Cyhoeddwyd: (2011)

Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study.
gan: Pouwels, S, et al.
Cyhoeddwyd: (2011)

Risk of hip fracture after stroke: A population-based case-control study
gan: Pouwels, S, et al.
Cyhoeddwyd: (2009)

Use of organic nitrates and the risk of hip fracture: A population-based case-control study
gan: Lalmohamed, A, et al.
Cyhoeddwyd: (2009)

USE OF ORGANIC NITRATES AND THE RISK OF HIP FRACTURE: A POPULATION-BASED CASE-CONTROL STUDY
gan: Lalmohamed, A, et al.
Cyhoeddwyd: (2009)

Use of Organic Nitrates and the Risk of Hip Fracture: A Population-Based Case-Control Study
gan: Lalmohamed, A, et al.
Cyhoeddwyd: (2009)

Risk of Fracture and Bone Mineral Density in Stroke Response
gan: Pouwels, S, et al.
Cyhoeddwyd: (2010)

Use of organic nitrates and the risk of hip fracture: a population-based case-control study.
gan: Pouwels, S, et al.
Cyhoeddwyd: (2010)

Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study.
gan: Pouwels, S, et al.
Cyhoeddwyd: (2009)

Use of beta-2 agonists and risk of hip fracture
gan: De Vries, F, et al.
Cyhoeddwyd: (2006)

KNEE ARTHOPLASTY AND RISK OF HIP FRACTURE: A POPULATION-BASED CASE-CONTROL STUDY
gan: Lalmohamed, A, et al.
Cyhoeddwyd: (2010)

Response to letter by Tsuda
gan: Pouwels, S, et al.
Cyhoeddwyd: (2010)

Timing of stroke in patients undergoing total hip replacement and matched controls: a nationwide cohort study.
gan: Lalmohamed, A, et al.
Cyhoeddwyd: (2012)

Use of beta-2 agonists and risk of hip/femur fracture: a population-based case-control study.
gan: de Vries, F, et al.
Cyhoeddwyd: (2007)

Knee arthroplasty and risk of hip fracture: A population-based, case-control study
gan: Lalmohamed, A, et al.
Cyhoeddwyd: (2012)

Knee arthroplasty and risk of hip fracture: a population-based, case-control study.
gan: Lalmohamed, A, et al.
Cyhoeddwyd: (2012)

Knee arthroplasty and risk of hip fracture: a population-based, case-control study.
gan: Lalmohamed, A, et al.
Cyhoeddwyd: (2012)

Risk of fracture in patients with Guillain-Barre syndrome.
gan: Pouwels, S, et al.
Cyhoeddwyd: (2014)

Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study.
gan: de Vries, F, et al.
Cyhoeddwyd: (2007)

Inhaled corticosteroids and hip fracture: disease or drugs?
gan: van Staa, T, et al.
Cyhoeddwyd: (2003)

Use of anti-depressants and the risk of fracture of the hip or femur.
gan: van den Brand, M, et al.
Cyhoeddwyd: (2009)

Risk of gastrointestinal bleeding in patients undergoing total hip or knee replacement compared with matched controls: a nationwide cohort study.
gan: Lalmohamed, A, et al.
Cyhoeddwyd: (2013)

Risk of gastrointestinal bleeding in patients undergoing total hip or knee replacement compared with matched controls: A nationwide cohort study
gan: Lalmohamed, A, et al.
Cyhoeddwyd: (2013)

Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands.
gan: de Vries, F, et al.
Cyhoeddwyd: (2007)

Use of beta-blockers and risk of hip and vertebral fracture: relationships to daily and cumulative dose
gan: De Vries, F, et al.
Cyhoeddwyd: (2006)

USE OF THIAZOLIDINEDIONES AND RISK OF OSTEOPOROTIC FRACTURE: DISEASE OR DRUGS?
gan: Bazelier, M, et al.
Cyhoeddwyd: (2010)

Erratum: Use of anti-depressants and the risk of fracture of the hip or femur (Osteoporos Int (DOI 10.1007/s00198-009-0849-6))
gan: Van Den Brand, M, et al.
Cyhoeddwyd: (2009)

Use of alpha-blockers and the risk of hip/femur fractures.
gan: Souverein, P, et al.
Cyhoeddwyd: (2003)

Use of statins and risk of fractures.
gan: van Staa, T, et al.
Cyhoeddwyd: (2001)

Use of statins and risk of fractures.
gan: van Staa, T, et al.
Cyhoeddwyd: (2000)

Statins and fracture risk - Reply
gan: van Staa, T, et al.
Cyhoeddwyd: (2001)

Risk of fracture in patients with muscular dystrophies
gan: Pouwels, S, et al.
Cyhoeddwyd: (2014)

Risk of fracture in patients with muscular dystrophies.
gan: Pouwels, S, et al.
Cyhoeddwyd: (2014)

Inhaled corticosteroids and hip fracture: Disease or drugs? [2] (multiple letters)
gan: Van Staa, T, et al.
Cyhoeddwyd: (2003)

Use of statins, risk of fracture and age-band bias
gan: De Vries, F, et al.
Cyhoeddwyd: (2006)

Use of thiazide diuretics and risk of hip/femur fracture: A population-based case-control study and the first-ever meta-analysis of double blinded RCTs
gan: De Vries, F, et al.
Cyhoeddwyd: (2008)